BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31361777)

  • 1. Antitumor activity of novel pyrazole-based small molecular inhibitors of the STAT3 pathway in patient derived high grade glioma cells.
    Zhang L; Peterson TE; Lu VM; Parney IF; Daniels DJ
    PLoS One; 2019; 14(7):e0220569. PubMed ID: 31361777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical characterization of signal transducer and activator of transcription 3 small molecule inhibitors for primary and metastatic brain cancer therapy.
    Assi HH; Paran C; VanderVeen N; Savakus J; Doherty R; Petruzzella E; Hoeschele JD; Appelman H; Raptis L; Mikkelsen T; Lowenstein PR; Castro MG
    J Pharmacol Exp Ther; 2014 Jun; 349(3):458-69. PubMed ID: 24696041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Jak2 small molecule inhibitor, G6, reduces the tumorigenic potential of T98G glioblastoma cells in vitro and in vivo.
    Baskin R; Park SO; Keserű GM; Bisht KS; Wamsley HL; Sayeski PP
    PLoS One; 2014; 9(8):e105568. PubMed ID: 25162558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling.
    Wu ATH; Huang HS; Wen YT; Lawal B; Mokgautsi N; Huynh TT; Hsiao M; Wei L
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells.
    Ciaglia E; Torelli G; Pisanti S; Picardi P; D'Alessandro A; Laezza C; Malfitano AM; Fiore D; Pagano Zottola AC; Proto MC; Catapano G; Gazzerro P; Bifulco M
    Oncotarget; 2015 Jun; 6(17):15464-81. PubMed ID: 26008966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
    Pan L; Chen X; Fu S; Yu W; Li C; Wang T; Lo HW; Lin J
    Breast Cancer Res Treat; 2020 May; 181(1):31-41. PubMed ID: 32240456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators.
    Lo HW; Cao X; Zhu H; Ali-Osman F
    Clin Cancer Res; 2008 Oct; 14(19):6042-54. PubMed ID: 18829483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxamic Acid and Benzoic Acid-Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes In Vitro and In Vivo.
    Yue P; Lopez-Tapia F; Paladino D; Li Y; Chen CH; Namanja AT; Hilliard T; Chen Y; Tius MA; Turkson J
    Cancer Res; 2016 Feb; 76(3):652-63. PubMed ID: 26088127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
    Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
    Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma.
    Miklossy G; Youn UJ; Yue P; Zhang M; Chen CH; Hilliard TS; Paladino D; Li Y; Choi J; Sarkaria JN; Kawakami JK; Wongwiwatthananukit S; Chen Y; Sun D; Chang LC; Turkson J
    J Med Chem; 2015 Oct; 58(19):7734-48. PubMed ID: 26331426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells.
    Gu J; Li G; Sun T; Su Y; Zhang X; Shen J; Tian Z; Zhang J
    J Neurooncol; 2008 Aug; 89(1):9-17. PubMed ID: 18415045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A natural compound derivative P-13 inhibits STAT3 signaling by covalently inhibiting Janus kinase 2.
    Huang H; Niu J; Wang F; Hu L; Yu Q
    Invest New Drugs; 2019 Jun; 37(3):452-460. PubMed ID: 30073465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor Activity of Novel Signal Transducer and Activator of Transcription 3 Inhibitors on Retinoblastoma.
    Jo DH; Lee S; Bak E; Cho CS; Han YT; Kim K; Suh YG; Kim JH
    Mol Pharmacol; 2021 Jul; 100(1):63-72. PubMed ID: 34016717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
    Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
    Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrandrine suppresses human glioma growth by inhibiting cell survival, proliferation and tumour angiogenesis through attenuating STAT3 phosphorylation.
    Ma JW; Zhang Y; Li R; Ye JC; Li HY; Zhang YK; Ma ZL; Li JY; Zhong XY; Yang X
    Eur J Pharmacol; 2015 Oct; 764():228-239. PubMed ID: 26086859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres.
    Mukthavaram R; Ouyang X; Saklecha R; Jiang P; Nomura N; Pingle SC; Guo F; Makale M; Kesari S
    J Transl Med; 2015 Aug; 13():269. PubMed ID: 26283544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells.
    Swiatek-Machado K; Mieczkowski J; Ellert-Miklaszewska A; Swierk P; Fokt I; Szymanski S; Skora S; Szeja W; Grynkiewicz G; Lesyng B; Priebe W; Kaminska B
    Cancer Biol Ther; 2012 Jun; 13(8):657-70. PubMed ID: 22555804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma.
    Tong L; Li J; Li Q; Wang X; Medikonda R; Zhao T; Li T; Ma H; Yi L; Liu P; Xie Y; Choi J; Yu S; Lin Y; Dong J; Huang Q; Jin X; Lim M; Yang X
    Theranostics; 2020; 10(13):5943-5956. PubMed ID: 32483429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells.
    Chang CH; Liu WT; Hung HC; Gean CY; Tsai HM; Su CL; Gean PW
    BMC Cancer; 2017 Dec; 17(1):905. PubMed ID: 29284440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.